Streetbeat News

Stock Prices

PGY

UPST

Wedbush Securities analysts warn of persistent funding challenges in the loan market despite a rally in shares amid a decline in treasury yields. Upstart Holdings Inc (UPST), LendingClub Corp (LC), and Pagaya Technologies Ltd (PGY) were discussed at the Disruptive Finance Forum. Upstart retains an Underperform rating with a $10 price target due to business model and credit quality pressures. Pagaya has a Neutral rating with a $2 price target, performing better than peers. LendingClub maintains an Outperform rating with an $8 price target, favored for its credit quality and business model durability.

Portfolio Pulse from Vandana Singh

December 04, 2023 | 6:17 pm

CBDD

CBD of Denver Inc (OTCPK: CBDD) has announced the creation of Luxora Real Estate AG in Switzerland, with plans to invest in German commercial real estate. Luxora aims to raise 10 million CHF to purchase properties and convert them into indoor farming facilities for lease to cannabis clubs in Germany. The company has already targeted two properties in Berlin, aligning with upcoming cannabis regulations in July 2024. CBDD's shares were trading at $0.0007 at the time of the report.

Portfolio Pulse from Patricio Liddle

December 04, 2023 | 6:16 pm

GDX

GOLD

KGC

NEM

Gold has reached a record high of over $2,146 per ounce, yet gold mining stocks have not seen similar gains, with the VanEck Gold Miners ETF (GDX) 50% below its 2011 peak. Rising production costs, stock dilution, local opposition, and a fragmented industry are cited as reasons for the underperformance. Oliver Groß points to increased costs in energy, labor, and operations, while Ima Casanova of VanEck sees gold stocks as undervalued and poised for a re-evaluation.

Portfolio Pulse from Piero Cingari

December 04, 2023 | 6:11 pm

ALK

ATHE

EYPT

SSNT

UCAR

U Power Limited (NASDAQ:UCAR) shares plummeted by 54% after announcing a follow-on offering of 10 million units at $1.20 each. EyePoint Pharmaceuticals (NASDAQ:EYPT), Hawaiian Holdings (NASDAQ:HA), and Alterity Therapeutics (NASDAQ:ATHE) saw significant gains following positive trial results, acquisition news, and conference presentations, respectively. SilverSun Technologies (NASDAQ:SSNT) surged after a $1 billion investment announcement. Other notable movers included Bit Brother (NASDAQ:BETS), Lucy Scientific Discovery (NASDAQ:LSDI), and View, Inc. (NASDAQ:VIEW). On the downside, NexImmune (NASDAQ:NEXI), Meta Materials (NASDAQ:MMAT), and Clean Earth Acquisitions Corp. (NASDAQ:CLIN) experienced substantial losses. Alaska Air Group (NYSE:ALK) announced plans to acquire Hawaiian Holdings, causing its own shares to drop by 15.1%.

Portfolio Pulse from Lisa Levin

December 04, 2023 | 6:10 pm

OWL

Evercore ISI Group analyst Glenn Schorr has maintained an Outperform rating on Blue Owl Capital (NYSE:OWL) and increased the price target from $14 to $15.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 6:03 pm

DTE

Evercore ISI Group analyst Durgesh Chopra has maintained an Outperform rating on DTE Energy (NYSE:DTE) and increased the price target from $108 to $116.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 6:01 pm

SBSW

Sibanye Stillwater (NYSE:SBSW) has received 4 analyst ratings in the last quarter, with 2 somewhat bullish and 2 indifferent, and no bearish ratings. The average 12-month price target among these analysts is $7.0, with a high of $9.00 and a low of $5.50. This average price target represents a 25.37% decrease from the previous average price target of $9.38.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 6:00 pm

PATH

Over the past 3 months, 17 Wall Street analysts have published their opinions on UiPath (NYSE:PATH), with an average 12-month price target of $20.82, a high of $25.00, and a low of $17.00. The consensus shows 5 bullish, 1 somewhat bullish, and 11 indifferent ratings. The average price target has increased by 12.54% over the past month.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 6:00 pm

GPN

Global Payments (NYSE:GPN) has delivered an average annual return of 12.25% over the past 20 years, outperforming the market by 4.77% on an annualized basis. A $1000 investment in GPN stock 20 years ago would be worth $10,350.75 today. The company currently has a market capitalization of $31.08 billion.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 6:00 pm

NPCE

Over the past 3 months, 5 analysts have provided their opinions on NeuroPace (NASDAQ:NPCE) stock, with 2 somewhat bullish and 3 indifferent ratings. The average price target is $9.2, representing an upside from the current price of $8.69. This target has increased by 41.54% from the previous target of $6.50. Analyst ratings are based on company data, financial statements, and insider information, and are intended to predict stock performance.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 6:00 pm